These increases were not associated with Ursodeoxycholic acid (UDCA) therapy (Supplementary Figures 2A,B) and were specific to NK cells, as there was no increase in the frequencies CD3+CD56- T-cells expressing CXCR6 or CD49a in PBC patients (Figure 1C). The gene discussed is ITGA1; the disease is primary biliary cholangitis.